Substandard and falsified vaccines erode the public's trust in vaccines and hinder our ability to control the COVID-19 pandemic. To help ensure the quality of vaccines, USP offers its quality standards, best practices, and insights to guide manufacturing, packaging, and release processes. Our goal is to help increase access to quality-assured COVID-19 vaccines.

White Paper: Confronting Substandard and Falsified COVID-19 Vaccines
Strategies and tools for use in global settings



Best practices and strategies for testing COVID-19 vaccines

Operational considerations for healthcare practitioners